Transdermal patch containing diclofenac epolamine and preparation method of transdermal patch

A technology of diclofenac epoamide and transdermal patch is applied to the transdermal patch containing diclofenac epoamide and the field of preparation thereof, and can solve the problems of low drug utilization rate, low drug permeability of the transdermal patch and the like

Inactive Publication Date: 2020-10-27
NANJING HEALTHNICE MEDICAL TECH +2
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the transdermal patch disclosed in this patent has low drug permeability, resulting in low drug utilization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Mix 1% eporamide diclofenac, 5% laurocaprolactone, 5% limonene and 89% gel matrix to make a drug-loaded gel, and apply the drug-loaded gel to the release layer The thickness of the gel layer after drying is about 80 μm, and the drug-loaded gel layer is formed after drying at 70° C., the surface of the drug-loaded gel layer is covered with an anti-adhesive layer, and cut into patches.

Embodiment 2

[0036] Diclofenac eporamide 2%, laurocaprolactone 3%, limonene 8% and 87% gel matrix are mixed uniformly to make drug-loaded gel, and this drug-loaded gel is coated on the release layer, so that After drying, the thickness of the gel layer is about 80 μm. After drying at 75° C., a drug-loaded gel layer is formed. The surface of the drug-loaded gel layer is covered with an anti-adhesive layer and cut into patches.

Embodiment 3

[0038] Mix 3% eporamide diclofenac, 2% laurocaprolactone, 8% limonene and 87% gel matrix to make a drug-loaded gel, and apply the drug-loaded gel to the release layer The thickness of the gel layer after drying is about 80 μm, and the drug-loaded gel layer is formed after drying at 80° C., the surface of the drug-loaded gel layer is covered with an anti-adhesive layer, and cut into patches.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention relates to a transdermal patch containing diclofenac epolamine and a preparation method of the transdermal patch. The transdermal patch comprises a back lining layer and a medicine carrying gel layer coated to the surface of the back lining layer, wherein the medicine carrying gel layer consists of active components of the diclofenac epolamine, a penetrating agent and gel made from agel substrate; and the penetrating agent consists of laurocapram and limonene. The laurocapram and the limonene are used as the penetrating agent to prepare the transdermal patch containing diclofenac epolamine, and the transdermal patch containing diclofenac epolamine is used for relieving pain of muscle, parenchyma and joints, and has excellent osmotic effects.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a transdermal patch containing diclofenac eporamide and a preparation method thereof. Background technique [0002] Transdermal patch refers to a thin-skinned preparation that can be attached to the skin, and the percutaneous absorption of the drug will produce systemic or local therapeutic effects. The advantage of transdermal preparations is that there is no liver first-pass effect, and it is not affected by the gastric emptying rate. High bioavailability, easy to use, no pain, can withdraw or interrupt treatment at any time, accurate dosage, fixed absorption area, stable blood drug concentration, no rosin and other thickeners, less irritation to the skin, prolong the action time, reduce Therefore, it has been widely studied and applied in the field of pharmaceutical preparations in recent years. [0003] Diclofenac eporamide is a powerful non-steroidal anti-inflamma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K31/196A61K31/40A61K47/22A61K47/06A61K47/42A61K47/12A61K47/10A61K47/32A61P29/00
CPCA61K9/7023A61K31/196A61K31/40A61K47/06A61K47/10A61K47/12A61K47/22A61K47/32A61K47/42A61P29/00
Inventor 徐丽殷坤郭金花王华娟
Owner NANJING HEALTHNICE MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap